Table 2

Cytotoxicity and expansion of human tk+ mH antigen-specific CTLs after IL-7Rα sequential sorting

CTLs*IL-7Rα+, %Sorting
IL-7Rα+, %Re-sorting
IL-7Rα, %Cytotoxicity,§ %Expansion, foldIL-7Rα, %Cytotoxicity,§ %Expansion, fold
HA1-tk #1 32.9 92.4pos 12.7 17.6 12.6 95.3pos 21.2 10.4 
< 1neg 65.7 4.1 < 1neg 78.5 4.7 
HA1-tk #2 54.6 86.7pos 16.8 24.2 10.9 91.7pos 11.5 14.5 
2.3neg 54.2 4.6 1.8neg 84.5 — 
HY-tk #1 21.7 81.8pos 21.2 35.1 15.4 89.6pos 22.6 12.3 
5.6neg 74.0 8.7 1.5neg 81.2 3.5 
CTLs*IL-7Rα+, %Sorting
IL-7Rα+, %Re-sorting
IL-7Rα, %Cytotoxicity,§ %Expansion, foldIL-7Rα, %Cytotoxicity,§ %Expansion, fold
HA1-tk #1 32.9 92.4pos 12.7 17.6 12.6 95.3pos 21.2 10.4 
< 1neg 65.7 4.1 < 1neg 78.5 4.7 
HA1-tk #2 54.6 86.7pos 16.8 24.2 10.9 91.7pos 11.5 14.5 
2.3neg 54.2 4.6 1.8neg 84.5 — 
HY-tk #1 21.7 81.8pos 21.2 35.1 15.4 89.6pos 22.6 12.3 
5.6neg 74.0 8.7 1.5neg 81.2 3.5 
*

Thymidine kinase–positive CTLs used for sorting: HA1-tk #1, specific for HA-1 and induced from an HLA-A2pos/HA-1neg donor; HA1-tk #2, specific for HA-1 and induced from a second HLA-A2pos/HA-1neg donor; HY-tk #1, specific for H-Y and induced from an HLA-A2pos/H-Yneg (female) donor

Thymidine kinase–positive mH antigen-specific CTLs expressing IL-7Rα

Thymidine kinase–positive mH antigen-specific CTLs expressing IL-7Rα in the positive (pos) and in the negative (neg) fraction after IL-7Rα sorting

§

Cytotoxicity of IL-7Rα+ and IL-7Rαtk+ mH antigen-specific CTLs against an LCL expressing the relevant mH antigen at a 20:1 ratio

Expansion of IL-7Rα+ and IL-7Rαtk+ mH antigen-specific CTLs

Close Modal

or Create an Account

Close Modal
Close Modal